Should elderly heart failure patients be treated with β-blockade therapy?

Nature Clinical Practice Cardiovascular Medicine

Volumn 2, Issue 1, 2005, Pages 14-15

  Swedberg, Karl ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

blockers; Elderly patients; Heart failure

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; METOPROLOL SUCCINATE; PLACEBO; VASODILATOR AGENT;

CLINICAL TRIAL; DEATH; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; ELDERLY CARE; FOLLOW UP; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART RATE; HOSPITALIZATION; HUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL; RISK REDUCTION; SHORT SURVEY; SUSTAINED RELEASE FORMULATION;

EID: 20444437679     PISSN: 17434297     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncpcardio0077     Document Type: Short Survey

References (6)

1. Remme WJ and Swedberg K (2001) Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 22: 1527-1560
2. The CONSENSUS Trial Study Group (1987) Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 316: 1429-1435
3. The SOLVD Investigators (1991) Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325: 293-302
4. Erdmann E et al. (2001) Results from post-hoc analyses of the CIBIS II trial: effect of bisoprolol in high-risk patient groups with chronic heart failure. Eur J Heart Fail 3: 469-479
5. Packer M et al. (2001) Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344: 1651-1658
6. Cleland JGF et al. (2004) Clinical trials update from the European Society of Cardiology: SENIORS, ACES, PROVE-IT, ACTION, and the HF-ACTION trial. Eur J Heart Fail 6: 787-791